CORRECT: Abbott Gets FDA Approval for Aveir Leadless Pacemaker

Abbott says the FDA has approved the Aveir single-chamber leadless pacemaker for the treatment of patients in the U.S. with slow heart rhythms.

• Pacemaker includes mapping capability to assess correct positioning prior to placement
• Increased projected battery life that can be as much as two times longer than other currently commercially available leadless pacemakers
• Abbott will continue to explore new ways to treat abnormal heart rhythms, said Randel Woodgrift, senior vice president, Cardiac Rhythm Management, Abbott
• Link to statement

(Corrects spelling of company name)

To contact the reporter on this story:
Georgi Azar in New York at gazar4@bloomberg.net

To contact ...